Pages that link to "Q28363547"
Jump to navigation
Jump to search
The following pages link to Increased ability for selection of zidovudine resistance in a distinct class of wild-type HIV-1 from drug-naive persons (Q28363547):
Displaying 50 items.
- Minority HIV-1 drug resistance mutations are present in antiretroviral treatment-naïve populations and associate with reduced treatment efficacy (Q28473296) (← links)
- Persistence of transmitted HIV-1 drug resistance mutations associated with fitness costs and viral genetic backgrounds (Q28544845) (← links)
- Geographic and temporal trends in the molecular epidemiology and genetic mechanisms of transmitted HIV-1 drug resistance: an individual-patient- and sequence-level meta-analysis (Q28545866) (← links)
- Epidemiological Surveillance of HIV-1 Transmitted Drug Resistance in Spain in 2004-2012: Relevance of Transmission Clusters in the Propagation of Resistance Mutations (Q28547497) (← links)
- Time trends in drug resistant HIV-1 infections in the United Kingdom up to 2009: multicentre observational study (Q28728325) (← links)
- A fossil record of zidovudine resistance in transmitted isolates of HIV-1 (Q28775685) (← links)
- Using drug exposure for predicting drug resistance - A data-driven genotypic interpretation tool (Q30000270) (← links)
- Characterization of the patterns of drug-resistance mutations in newly diagnosed HIV-1 infected patients naïve to the antiretroviral drugs (Q33483060) (← links)
- Deciphering Evolutionary Mechanisms Between Mutualistic and Pathogenic Symbioses (Q33490644) (← links)
- Transmitted antiretroviral drug resistance among acute and recent HIV infections in North Carolina from 1998 to 2007 (Q33814896) (← links)
- Characterization of drug-resistance mutations in HIV type 1 isolates from drug-naive and ARV-treated patients in Bulgaria (Q34083250) (← links)
- Prevalence of transmitted HIV-1 antiretroviral resistance among patients initiating antiretroviral therapy in Brazil: a surveillance study using dried blood spots. (Q34232916) (← links)
- A multicenter study of initiation of antiretroviral therapy and transmitted drug resistance in antiretroviral-naive adolescents and young adults with HIV in New York City (Q34398159) (← links)
- High viremia and low level of transmitted drug resistance in anti-retroviral therapy-naïve perinatally-infected children and adolescents with HIV-1 subtype C infection (Q34484449) (← links)
- Persistence of frequently transmitted drug-resistant HIV-1 variants can be explained by high viral replication capacity. (Q34677368) (← links)
- Zidovudine: a review of its use in the management of vertically-acquired pediatric HIV infection (Q34749066) (← links)
- A novel genetic pathway of human immunodeficiency virus type 1 resistance to stavudine mediated by the K65R mutation (Q34976902) (← links)
- HIV mutagenesis and the evolution of antiretroviral drug resistance (Q35046890) (← links)
- Major HIV resistance mutations in untreated Romanian patients. (Q35071197) (← links)
- Rates of transmission of antiretroviral drug resistant strains of HIV-1. (Q35071446) (← links)
- Infectivity and replication capacity of drug-resistant human immunodeficiency virus type 1 variants isolated during primary infection (Q35104695) (← links)
- Transmitted human immunodeficiency virus type 1 carrying the D67N or K219Q/E mutation evolves rapidly to zidovudine resistance in vitro and shows a high replicative fitness in the presence of zidovudine (Q35122204) (← links)
- Japanese external quality assessment program to standardize HIV-1 drug-resistance testing (JEQS2010 program) using in vitro transcribed RNA as reference material (Q35141797) (← links)
- Clinical management of HIV drug resistance (Q35261045) (← links)
- Consensus drug resistance mutations for epidemiological surveillance: basic principles and potential controversies. (Q35300021) (← links)
- Mutations in the connection domain of HIV-1 reverse transcriptase increase 3'-azido-3'-deoxythymidine resistance (Q35576015) (← links)
- Drug resistance in non-subtype B HIV-1. (Q35667018) (← links)
- Transmitted HIV Drug Resistance Is High and Longstanding in Metropolitan Washington, DC (Q36053733) (← links)
- Viruses as quasispecies: biological implications (Q36433889) (← links)
- Approach to salvage antiretroviral therapy in heavily antiretroviral-experienced HIV-positive adults (Q36548076) (← links)
- HIV-1 protease and reverse transcriptase mutations for drug resistance surveillance (Q36696351) (← links)
- Nucleoside reverse transcriptase inhibitor resistance mutations associated with first-line stavudine-containing antiretroviral therapy: programmatic implications for countries phasing out stavudine (Q36852626) (← links)
- HIV-1 drug resistance mutations: an updated framework for the second decade of HAART (Q36900010) (← links)
- Active methamphetamine use is associated with transmitted drug resistance to non-nucleoside reverse transcriptase inhibitors in individuals with HIV infection of unknown duration (Q36914858) (← links)
- Minority human immunodeficiency virus type 1 variants in antiretroviral-naive persons with reverse transcriptase codon 215 revertant mutations. (Q36949610) (← links)
- Clinical significance of human immunodeficiency virus type 1 replication fitness (Q36969857) (← links)
- Antiretroviral therapy : optimal sequencing of therapy to avoid resistance (Q37032556) (← links)
- HIV-1 reverse transcriptase inhibitor resistance mutations and fitness: a view from the clinic and ex vivo. (Q37090735) (← links)
- Comparison of algorithms that interpret genotypic HIV-1 drug resistance to determine the prevalence of transmitted drug resistance (Q37277757) (← links)
- Aptamer-based therapeutics: new approaches to combat human viral diseases (Q37415958) (← links)
- Impact of nelfinavir resistance mutations on in vitro phenotype, fitness, and replication capacity of human immunodeficiency virus type 1 with subtype B and C proteases (Q37489580) (← links)
- Evolutionary pathways of transmitted drug-resistant HIV-1. (Q37866540) (← links)
- Mechanism of HIV antiretroviral drugs progress toward drug resistance (Q37961181) (← links)
- Molecular determinants of multi-nucleoside analogue resistance in HIV-1 reverse transcriptases containing a dipeptide insertion in the fingers subdomain: effect of mutations D67N and T215Y on removal of thymidine nucleotide analogues from blocked DN (Q38343144) (← links)
- Combination of drugs and drug-resistant reverse transcriptase results in a multiplicative increase of human immunodeficiency virus type 1 mutant frequencies (Q39684476) (← links)
- Commonly Transmitted HIV-1 Drug Resistance Mutations in Reverse-Transcriptase and Protease in Antiretroviral Treatment-Naive Patients and Response to Regimens Containing Tenofovir Disoproxil Fumarate or Tenofovir Alafenamide (Q40223002) (← links)
- Relative replication fitness of multi-nucleoside analogue-resistant HIV-1 strains bearing a dipeptide insertion in the fingers subdomain of the reverse transcriptase and mutations at codons 67 and 215. (Q40533802) (← links)
- HIV-1 subtypes and drug resistance profiles in a cohort of heterosexual patients in Istanbul, Turkey (Q41009267) (← links)
- Trends in prevalence of HIV-1 drug resistance in Thailand 2009-2010. (Q42269396) (← links)
- Factors limiting the transmission of HIV mutations conferring drug resistance: fitness costs and genetic bottlenecks (Q42577298) (← links)